CaRi-Heart® for comprehensive quantification of coronary inflammation, plaque and risk
![Scientific Presentation](https://www.caristo.com/wp-content/uploads/2024/04/SCCT-Winter-2-scaled.jpg)
Prof. Keith Channon, Chair of Cardiovascular Medicine at the University of Oxford and Chief Medical Officer at Caristo Diagnostics, presented the latest developments on CaRi-Heart® technology and shared findings from the ORFAN study at SCCT Global Meeting 2024, in Budapest. The findings demonstrate the potential for Fat Attenuation Index Score (FAI-Score) to transform risk stratification and management of patients with coronary artery disease.
Watch his presentation here.